Literature DB >> 26420613

Biobanking for Personalized Medicine.

Angen Liu1, Kai Pollard2.   

Abstract

A biobank is an entity that collects, processes, stores, and distributes biospecimens and relevant data for use in basic, translational, and clinical research. Biobanking of high-quality human biospecimens such as tissue, blood and other bodily fluids along with associated patient clinical information provides a fundamental scientific infrastructure for personalized medicine. Identification of biomarkers that are specifically associated with particular medical conditions such as cancer, cardiovascular disease and neurological disorders are useful for early detection, prevention, and treatment of the diseases. The ability to determine individual tumor biomarkers and to use those biomarkers for disease diagnosis, prognosis and prediction of response to therapy is having a very significant impact on personalized medicine and is rapidly changing the way clinical care is conducted. As a critical requirement for personalized medicine is the availability of a large collection of patient samples with well annotated patient clinical and pathological data, biobanks thus play an important role in personalized medicine advancement. The goal of this chapter is to explore the role of biobanks in personalized medicine and discuss specific needs regarding biobank development for translational and clinical research, especially for personalized medicine advancement.

Entities:  

Keywords:  Biobank; Biospecimen; Cancer; Pathology; Personalized medicine

Mesh:

Year:  2015        PMID: 26420613     DOI: 10.1007/978-3-319-20579-3_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Large-Scale Genomic Biobanks and Cardiovascular Disease.

Authors:  Aeron M Small; Christopher J O'Donnell; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

2.  Cryopreservation of GABAergic Neuronal Precursors for Cell-Based Therapy.

Authors:  Daniel Rodríguez-Martínez; María Magdalena Martínez-Losa; Manuel Alvarez-Dolado
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

3.  Biobanks and Individual Health Related Findings: from an Obstacle to an Incentive.

Authors:  Jurate Lekstutiene; Søren Holm; Eugenijus Gefenas
Journal:  Sci Eng Ethics       Date:  2021-08-11       Impact factor: 3.525

4.  Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability.

Authors:  Carmel M Quinn; Mamta Porwal; Nicola S Meagher; Anusha Hettiaratchi; Carl Power; Jitendra Jonnaggadala; Sue McCullough; Stephanie Macmillan; Katrina Tang; Winston Liauw; David Goldstein; Nikolajs Zeps; Philip J Crowe
Journal:  Biomark Insights       Date:  2021-03-27

5.  The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.

Authors:  Anna Chróścicka; Angelika Paluch; Łukasz Kozera; Małgorzata Lewandowska-Szumieł
Journal:  J Transl Med       Date:  2021-06-22       Impact factor: 5.531

6.  Ultra-fast vitrification of patient-derived circulating tumor cell lines.

Authors:  Rebecca D Sandlin; Keith H K Wong; Shannon N Tessier; Anisa Swei; Lauren D Bookstaver; Bennett E Ahearn; Shyamala Maheswaran; Daniel A Haber; Shannon L Stott; Mehmet Toner
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

7.  Biobanking in Molecular Biomarker Research for the Early Detection of Cancer.

Authors:  Kim Lommen; Selena Odeh; Chiel C de Theije; Kim M Smits
Journal:  Cancers (Basel)       Date:  2020-03-25       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.